2000
DOI: 10.1016/s0016-5085(00)84705-8
|View full text |Cite
|
Sign up to set email alerts
|

A phase II study of gastrimmune in advanced pancreatic cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2002
2002
2003
2003

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Results from studies in gastric and pancreatic cancer using gastrimmine are reported in preliminary form only (Brett et al 2000; Watson & Gilliam 2001). It is reported in these preliminary reports that gastrimmune increased the duration of survival in patients with advanced pancreatic carcinoma (Brett et al 2000; Watson & Gilliam 2001).…”
mentioning
confidence: 99%
“…Results from studies in gastric and pancreatic cancer using gastrimmine are reported in preliminary form only (Brett et al 2000; Watson & Gilliam 2001). It is reported in these preliminary reports that gastrimmune increased the duration of survival in patients with advanced pancreatic carcinoma (Brett et al 2000; Watson & Gilliam 2001).…”
mentioning
confidence: 99%